Collaboration
Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
Allergan, plc
PR-M08-18-NI-062Aug 17, 2018
Cell and Gene Therapy
Editas Founders Start New Gene Editing Company
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-011May 17, 2018